Elsevier

The Lancet Oncology

Volume 22, Issue 5, May 2021, Pages 581-583
The Lancet Oncology

Comment
Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors

https://doi.org/10.1016/S1470-2045(21)00155-8Get rights and content

Cited by (0)

View Abstract